A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies

Inclusion Criteria: * Patients with histologically documented diagnosis of one of the following lymphoid malignancies: * Hodgkin Lymphoma; * Mantle Cell Lymphoma; * Indolent Lymphoma (including follicular lymphoma, lymphoplasmacytic lymphoma, marginal zone lymphoma and small lymphocytic lymphoma); * Patients must have received at least one prior treatment regimen; patients with Hodgkin Lymphoma must have received an autologous stem cell transplant, refused or been deemed ineligible for stem cell transplant; * Able to understand and willing to sign the informed consent form. Exclusion Criteria: * Any histology other than Hodgkin Lymphoma, Mantle Cell Lymphoma or Indolent Lymphoma; * History of or active Central Nervous System (CNS) malignancy; * Active graft-versus-host disease (GVHD);